Association of 15-hydroxyprostaglandin dehydrogenate and poor prognosis of obese breast cancer patients

MLA

Huihua Xiong, et al. “Association of 15-Hydroxyprostaglandin Dehydrogenate and Poor Prognosis of Obese Breast Cancer Patients.” Oncotarget, vol. 8, no. 14, Feb. 2017, pp. 22842–53. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f32503a6649c2bd71e871383b1a8ec8&authtype=sso&custid=ns315887.

APA

Huihua Xiong, Xiyou Liu, Ya Wang, Shiying Yu, Fei Liu, Tao Liu, Ruxing Wu, Liang Zhuang, Peiwen Yang, & Xiaoyuan Huang. (2017). Association of 15-hydroxyprostaglandin dehydrogenate and poor prognosis of obese breast cancer patients. Oncotarget, 8(14), 22842–22853.

Chicago

Huihua Xiong, Xiyou Liu, Ya Wang, Shiying Yu, Fei Liu, Tao Liu, Ruxing Wu, Liang Zhuang, Peiwen Yang, and Xiaoyuan Huang. 2017. “Association of 15-Hydroxyprostaglandin Dehydrogenate and Poor Prognosis of Obese Breast Cancer Patients.” Oncotarget 8 (14): 22842–53. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f32503a6649c2bd71e871383b1a8ec8&authtype=sso&custid=ns315887.